CN116870254A - 人自体胶原蛋白活细胞注射剂及其制备方法 - Google Patents
人自体胶原蛋白活细胞注射剂及其制备方法 Download PDFInfo
- Publication number
- CN116870254A CN116870254A CN202310947645.5A CN202310947645A CN116870254A CN 116870254 A CN116870254 A CN 116870254A CN 202310947645 A CN202310947645 A CN 202310947645A CN 116870254 A CN116870254 A CN 116870254A
- Authority
- CN
- China
- Prior art keywords
- solution
- autologous collagen
- collagen
- living cell
- self
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 59
- 108010035532 Collagen Proteins 0.000 title claims abstract description 59
- 229920001436 collagen Polymers 0.000 title claims abstract description 59
- 238000002347 injection Methods 0.000 title claims abstract description 42
- 239000007924 injection Substances 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 210000004027 cell Anatomy 0.000 claims abstract description 77
- 239000000017 hydrogel Substances 0.000 claims abstract description 52
- 239000000203 mixture Substances 0.000 claims abstract description 51
- 229920001287 Chondroitin sulfate Polymers 0.000 claims abstract description 32
- 229940059329 chondroitin sulfate Drugs 0.000 claims abstract description 32
- -1 aldehyde chondroitin sulfate Chemical class 0.000 claims abstract description 23
- 239000007788 liquid Substances 0.000 claims abstract description 23
- 108010039918 Polylysine Proteins 0.000 claims abstract description 22
- 210000002950 fibroblast Anatomy 0.000 claims abstract description 22
- 229920000656 polylysine Polymers 0.000 claims abstract description 22
- 102000009123 Fibrin Human genes 0.000 claims abstract description 15
- 108010073385 Fibrin Proteins 0.000 claims abstract description 15
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229950003499 fibrin Drugs 0.000 claims abstract description 15
- 238000002156 mixing Methods 0.000 claims abstract description 14
- 238000004132 cross linking Methods 0.000 claims abstract description 5
- 239000000243 solution Substances 0.000 claims description 43
- 239000011259 mixed solution Substances 0.000 claims description 31
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 28
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000006228 supernatant Substances 0.000 claims description 15
- 102000004142 Trypsin Human genes 0.000 claims description 14
- 108090000631 Trypsin Proteins 0.000 claims description 14
- 239000012588 trypsin Substances 0.000 claims description 14
- 102000029816 Collagenase Human genes 0.000 claims description 13
- 108060005980 Collagenase Proteins 0.000 claims description 13
- 229960002424 collagenase Drugs 0.000 claims description 13
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 9
- 239000000499 gel Substances 0.000 claims description 8
- 238000012258 culturing Methods 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 7
- 101000577180 Aspergillus oryzae (strain ATCC 42149 / RIB 40) Neutral protease 2 Proteins 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 108090000695 Cytokines Proteins 0.000 claims description 5
- 102000004127 Cytokines Human genes 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 230000004927 fusion Effects 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000008055 phosphate buffer solution Substances 0.000 claims description 5
- 239000013049 sediment Substances 0.000 claims description 5
- 238000010008 shearing Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 4
- 230000028327 secretion Effects 0.000 claims description 3
- 108090000145 Bacillolysin Proteins 0.000 claims description 2
- 102000035092 Neutral proteases Human genes 0.000 claims description 2
- 108091005507 Neutral proteases Proteins 0.000 claims description 2
- 230000029087 digestion Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 230000004083 survival effect Effects 0.000 abstract description 10
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 9
- 206010067484 Adverse reaction Diseases 0.000 abstract description 5
- 230000006838 adverse reaction Effects 0.000 abstract description 5
- 238000011049 filling Methods 0.000 abstract description 4
- 238000012423 maintenance Methods 0.000 abstract description 4
- 230000000052 comparative effect Effects 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 14
- 230000015556 catabolic process Effects 0.000 description 8
- 238000006731 degradation reaction Methods 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 241000699660 Mus musculus Species 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000011580 nude mouse model Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 125000003172 aldehyde group Chemical group 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 231100000820 toxicity test Toxicity 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000002262 Schiff base Substances 0.000 description 2
- 150000004753 Schiff bases Chemical class 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/362—Skin, e.g. dermal papillae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310947645.5A CN116870254B (zh) | 2023-07-31 | 2023-07-31 | 人自体胶原蛋白活细胞注射剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310947645.5A CN116870254B (zh) | 2023-07-31 | 2023-07-31 | 人自体胶原蛋白活细胞注射剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116870254A true CN116870254A (zh) | 2023-10-13 |
CN116870254B CN116870254B (zh) | 2024-02-09 |
Family
ID=88254863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310947645.5A Active CN116870254B (zh) | 2023-07-31 | 2023-07-31 | 人自体胶原蛋白活细胞注射剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116870254B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117643650A (zh) * | 2024-01-30 | 2024-03-05 | 哈尔滨悦之美芳华医疗美容门诊有限公司 | 一种皮下填充凝胶复合材料及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007139525A2 (en) * | 2006-05-31 | 2007-12-06 | Kemal Tunc Tiryaki | A method and a tissue material for use in the treatment of the skin defects and aging |
CN102488924A (zh) * | 2011-12-23 | 2012-06-13 | 侯强 | 自体活细胞软组织填充凝胶及其制备方法 |
MX2014009806A (es) * | 2014-08-14 | 2016-02-15 | Eduardo Alvaro Galue | Proceso de obtención de un implante de relleno celular facial de fibroblastos autologos dermales con fibrina autologa para la regeneracion de pliegues, marcas de acné, arrugas faciales/cuello, estrías y defectos de la piel. |
US20200268940A1 (en) * | 2017-05-15 | 2020-08-27 | Richard J. Miron | Liquid platelet-rich fibrin as a carrier system for biomaterials and biomolecules |
CN114569704A (zh) * | 2022-02-17 | 2022-06-03 | 成都清科生物科技有限公司 | 一种负载脂肪干细胞的自体富血小板纤维蛋白凝胶及其制备方法与应用 |
CN114836378A (zh) * | 2022-04-11 | 2022-08-02 | 江西龙卿堂科技有限公司 | 自体母乳干细胞的体外培养方法、注射剂及其在皮肤损伤修复中的应用 |
CN115429935A (zh) * | 2022-10-10 | 2022-12-06 | 桂林医学院 | 一种可注射性的交联硫酸软骨素水凝胶及其制备方法 |
-
2023
- 2023-07-31 CN CN202310947645.5A patent/CN116870254B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007139525A2 (en) * | 2006-05-31 | 2007-12-06 | Kemal Tunc Tiryaki | A method and a tissue material for use in the treatment of the skin defects and aging |
CN102488924A (zh) * | 2011-12-23 | 2012-06-13 | 侯强 | 自体活细胞软组织填充凝胶及其制备方法 |
MX2014009806A (es) * | 2014-08-14 | 2016-02-15 | Eduardo Alvaro Galue | Proceso de obtención de un implante de relleno celular facial de fibroblastos autologos dermales con fibrina autologa para la regeneracion de pliegues, marcas de acné, arrugas faciales/cuello, estrías y defectos de la piel. |
US20200268940A1 (en) * | 2017-05-15 | 2020-08-27 | Richard J. Miron | Liquid platelet-rich fibrin as a carrier system for biomaterials and biomolecules |
CN114569704A (zh) * | 2022-02-17 | 2022-06-03 | 成都清科生物科技有限公司 | 一种负载脂肪干细胞的自体富血小板纤维蛋白凝胶及其制备方法与应用 |
CN114836378A (zh) * | 2022-04-11 | 2022-08-02 | 江西龙卿堂科技有限公司 | 自体母乳干细胞的体外培养方法、注射剂及其在皮肤损伤修复中的应用 |
CN115429935A (zh) * | 2022-10-10 | 2022-12-06 | 桂林医学院 | 一种可注射性的交联硫酸软骨素水凝胶及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117643650A (zh) * | 2024-01-30 | 2024-03-05 | 哈尔滨悦之美芳华医疗美容门诊有限公司 | 一种皮下填充凝胶复合材料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN116870254B (zh) | 2024-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ruszczak | Effect of collagen matrices on dermal wound healing | |
Cui et al. | Collagen-tussah silk fibroin hybrid scaffolds loaded with bone mesenchymal stem cells promote skin wound repair in rats | |
US6383220B1 (en) | Artificial skin | |
Zheng et al. | Polydopamine-modified collagen sponge scaffold as a novel dermal regeneration template with sustained release of platelet-rich plasma to accelerate skin repair: a one-step strategy | |
CN110237303B (zh) | 天然组织来源的脱细胞骨膜基质凝胶材料的制备方法 | |
CN116870254B (zh) | 人自体胶原蛋白活细胞注射剂及其制备方法 | |
CN109593124B (zh) | 脐带间充质干细胞因子冻干粉及其制备方法 | |
US8685634B2 (en) | Neural scaffolds | |
Bushkalova et al. | Alginate-chitosan PEC scaffolds: A useful tool for soft tissues cell therapy | |
CN114606189A (zh) | 一种促进神经干细胞增殖分化的脱细胞脊髓- GelMA水凝胶复合材料支架 | |
JP2002526204A (ja) | 中和キトサンスポンジまたは中和キトサン/コラーゲン混合スポンジを用いる人工真皮構造物 | |
CN107254431B (zh) | 一种新型组织工程皮肤制备方法 | |
CN114404648A (zh) | 促进糖尿病创面修复可降解抗菌止血水凝胶的制备方法 | |
RU2425645C1 (ru) | Способ и трансплантат для лечения печеночной недостаточности | |
CN110755174B (zh) | 一种生物混合型人工血管及其制备方法 | |
CN105169494A (zh) | 一种组织工程皮肤的制备方法 | |
CN115584034B (zh) | 一种用于伤口修复的可注射水凝胶材料及其制备方法 | |
CN111001041A (zh) | 一种抗炎抗菌复合皮肤支架材料及制备方法 | |
CN107441561B (zh) | 一种主动引导组织再生修复的仿生胶原基材料的制备方法 | |
CN114451397B (zh) | 用于保存干细胞的凝胶制剂及其制备方法以及含有凝胶制剂和干细胞的药物组合物 | |
CN114949358A (zh) | 一种用于深部创面修复的复合材料及其制备方法 | |
Seo et al. | Reinforced bioartificial dermis constructed with collagen threads | |
KR100644078B1 (ko) | 양막과 생분해성 고분자로 구성된 이식용 진피대체물,이의 제조방법 및 용도 | |
CN112826983A (zh) | 一种心脏脱细胞基质修饰仿生膜及其制备和应用 | |
Shan et al. | Reconstruction of tracheal window‐shape defect by 3D printed polycaprolatone scaffold coated with Silk Fibroin Methacryloyl |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240122 Address after: 100039 Collective, No. 28 Fuxing Road, Haidian District, Beijing Applicant after: Bai Jin Country or region after: China Address before: Unit 103, Unit 106, Unit 107, Unit 108, Unit 01, Unit 109, Unit 109, Unit 110, Unit 111, and Unit 112 on the 1st floor, No. 39 East Fourth Ring Middle Road, Chaoyang District, Beijing, 100020 Applicant before: Beijing Chumei Medical Beauty Clinic Co.,Ltd. Country or region before: China |
|
GR01 | Patent grant | ||
GR01 | Patent grant |